Oral magnesium supplementation decreases alanine aminotransferase levels in obese women

Magnesium Research

Volumn 23, Issue 2, 2010, Pages 90-96

  Rodriguez Hernandez, Heriberto ^a,b   Cervantes Huerta, Miriam ^a,b   Rodriguez Moran, Martha ^a,b   Guerrero Romero, Fernando ^a,b  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b Research Group on Diabetes and Chronic Illnesses   (Mexico)

Author keywords

Alt; Hepatic inflammation; Hs crp; Magnesium; Magnesium chloride disclose; Systemic inflammation

Indexed keywords

ALANINE AMINOTRANSFERASE; MAGNESIUM;

ANTHROPOMETRY; ARTICLE; BLOOD; CLINICAL TRIAL; DIET SUPPLEMENTATION; ENZYMOLOGY; FEMALE; HUMAN; MIDDLE AGED; OBESITY; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ALANINE TRANSAMINASE; ANTHROPOMETRY; DIETARY SUPPLEMENTS; FEMALE; HUMANS; MAGNESIUM; MIDDLE AGED; OBESITY;

EID: 77954449043     PISSN: 09531424     EISSN: 19524021     Source Type: Journal    
DOI: 10.1684/mrh.2010.0204     Document Type: Article

References (27)

1. Wellen KE, Hotamisligli GS. Inflammation, stress and diabetes. J Clin Invest 2005; 115: 1111-9.
2. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346: 1221-31.
3. Ridker PM, Hennekens CH, Buring JE, Rifai N. C- reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342: 836-43.
4. Shivakumar K. Pro-fibrogenic effects of magnesium deficiency in the cardiovascular system. Magnes Res 2002; 15: 307-15.
5. Zhou Q, Olinescu RM, Kummerow FA. Influence of low magnesium concentrations in the medium on the antioxidant system in cultured human arterial endothelial cells. Magnes Res 1999; 12: 19-29.
6. Ichihara A, Suzuki H, Saruta T. Effects of magnesium on the renin-angiotensin-aldosterone system in human subjects. J Lab Clin Med 1993; 122: 432-40.
7. Rodriguez-Hernandez H, Gonzalez JL, Rodriguez-Moran M, Guerrero-Romero F. Hypomagnesemia, insulin resistance, and non-alcoholic steatohepatitis in obese subjects. Arch Med Res 2005; 36: 362-6.
8. Guerrero-Romero F, Rodriguez-Moran M. Relationship between serum magnesium levels and C-reactive protein concentration, in non-diabetic, non-hypertensive obese subjects. Int J Obes Relat Metab Disord 2002; 26: 469-74.
9. Almoznino-Sarafian D, Berman S, Mor A, Shteinshnaider M, Gorelik O, Tzur I, Alon I, Modai D, Cohen N. Magnesium and C-reactive protein in heart failure: an anti- inflammatory effect of magnesium administration? Eur J Nutr 2007; 46: 230-7.
10. Firoz M, Graber M. Bioavailability of US comercial magnesium preparations. Magnes Res 2001; 14: 257-62.
11. Laires MJ, Moreira H, Monteiro CP, Sardinha L, Limão F, Veiga L, Gonçalves A, Ferreira A, Bicho M. Magnesium, insulin resistance and body composition in healthy postmenopausal women. J Am Coll Nutr 2004; 23: 510S-513S.
12. Ford ES, Mokdad AH. Dietary magnesium intake in a national sample of US adults. J Nutr 2003; 133: 2879-82.
13. American Heart Association Nutrition Committee Lichtenstein AH, Appel LJ, Brands M. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee Circulation 2006; 114: 82-96.
14. Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 2003; 98: 960-7.
15. Festa A. D'Agostino RJr, Howard G, Mykkanen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: The Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000; 102: 42-7.
16. Anty R, Bekri S, Luciani N, Saint-Paul MC, Dahman M, Iannelli A, Amor IB, Staccini-Myx A, Huet PM, Gugen-heim J, Sadoul JL, Marchand-Brustel Y, Tran A, Gual P. The inflammatory C-reactive protein is increased in both liver and adipose tissue in severely obese patients independently from metabolic syndrome, type 2 diabetes, and NASH. Am J Gastroenterol 2006; 101: 1824-33.
17. Park SH, Kim BI, Yun JW, Kim JW, Park DI, Cho YK, Sung IK, Park CY, Sohn CI, Jeon WK, Kim H, Rhee EJ, Lee WY, Kim SW. 2004 Insulin resistance and Creactive protein as independent risk factors for non-alcoholic fatty liver disease in non-obese Asian men. J Gastroenterol Hepatol 2004; 19: 694-8.
18. Browning LM, Krebs JD, Siervo M, Hall RM, Finer N, Allison ME, Jebb SA. Inflammation is associated with liver function markers, independent of other metabolic risk factors in overweight women. Br J Vasc Dis 2008; 8: 73-6.
19. Browning LM, Krebs JD, Magee EC, Fruhbeck G, Jebb SA. Circulating Markers of Inflammation and Their Link to Indices of Adiposity. Obes Facts 2008; 1: 259-65.
20. Dominguez LJ, Barbagallo M, Lauretani F, Bandinelli S, Bos A, Corsi AM, Simonsick EM, Ferrucci L. Magne- sium and muscle performance in older persons: the InCHIANTI study. Am J Clin Nutr 2006; 84: 419-26.
21. Kramer JH, Mak IT, Phillips TM, Weglicki WB. Dietary magnesium intake influences circulating pro- inflammatory neuropeptide levels and loss of myocar- dial tolerance to postischemic stress. Exp Biol Med 2003; 228: 665-73.
22. King DE. Inflammation and elevation of C-reactive protein: does magnesium play a key role? Magnes Res 2009; 22: 57-9.
23. Sanyal A, Campbell-Sargent C, Mirshahi F. Non-alcoholic steatohepatitis: association on insulin resistance and mitochondrial abnormalities. Gastroenterology 2001; 120: 1183-92.
24. Song Y, Ridker PM, Manson JE, Cook NR, Buring JE, Liu S. Magnesium intake, C-reactive protein, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care 2005; 28: 1438-44.
25. King DE, Mainous 3rd AG, Geesey ME, Woolson RF. Dietary magnesium and C-reactive protein levels. J Am Coll Nutr 2005; 24: 166-71.
26. Bo S, Durazzo M, Guidi S, Carello M, Sacerdote C, Silli B, Rosato R, Cassader M, Gentile L, Pagano G. Dietary magnesium and fiber intakes and inflammatory and metabolic indicators in middle-aged subjects from a population-based cohort. Am J Clin Nutr 2006; 84: 1062-9.
27. Song Y, Li TY, van Dam RM, Manson JE, Hu FB. Mag- nesium intake and plasma concentrations of markers of systemic inflammation and endothelial dysfunction in women. Am J Clin Nutr 2007; 85: 1068-74.